Zdrowie i gospodarka · 22/08/2003

FDA Withdraws Draft Guidance on Nucleic Acid Testing of Pooled Plasma

The Food and Drug Administration (FDA) has withdrawn a draft guidance document from November 1999, which sought public comment on the development and implementation of nucleic acid testing (NAT) for infectious diseases, following its announcement in the Federal Register on November 26, 1999.